Matthew Miessau
Principal
District of Columbia, United States
18 investmentsMatthew Miessau is a Principal based in District of Columbia, United States. Matthew Miessau has backed 18 companies, including Confluence Life Sciences, Funderbeam and Edinburgh Molecular Imaging. Investment focus areas include Health Care, Genetics and Chemical Engineering.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (18)
| Industry | Stage | Website | |||
|---|---|---|---|---|---|
| 1 | Confluence Life Sciences | — | — | — | — |
| 2 | Funderbeam | — | — | — | — |
| 3 | Edinburgh Molecular Imaging | — | — | — | — |
| 4 | Topas Therapeutics | — | — | — | — |
| 5 | Caldan Therapeutics | — | — | — | — |
| 6 | Theolytics | — | — | — | — |
| 7 | Macomics | — | — | — | — |
| 8 | Eternygen | — | — | — | — |
| 9 | NodThera | — | — | — | — |
| 10 | Clyde Biosciences | — | — | — | — |
| 11 | Enterprise Therapeutics | — | — | — | — |
| 12 | AdoRx Therapeutics | — | — | — | — |
Showing 1–12 of 18
Page 1 of 2
Access Full Contact Information
Get Matthew Miessau's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
No credit card required
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.